QuidelOrtho Corporation (QDEL) Guidance & Earnings Results

On 2026-08-06 QuidelOrtho Corporation lowered guidance: "FY2026 revenue $2.52-2.60B (from $2.70-2.75B); adjusted EBITDA $540-560M (from…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

QDELQuidelOrtho CorporationFollow QDEL — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 941.5M
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 3 Nov, in 10 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
6 Aug 26	Lowered	FY2026 revenue $2.52-2.60B (from $2.70-2.75B); adjusted EBITDA $540-560M (from $615-630M) · full year
5 May 26	Lowered	Revenue $2.70-2.75B (from $2.7-2.9B), Adj. EBITDA $615-630M (from $630-670M), Adj. EPS $1.80-2.00 (from $2.00-2.42), FCF $100-120M (from $120-160M) · full year
15 Apr 26	Lowered	Preliminary Q1 2026 revenue $615-620M; full-year guidance low end achievable · full year
11 Feb 26	Raised	FY26 adjusted EBITDA $630-$670M vs FY25 $597M; free cash flow $120-$160M vs ($77M) · full year
5 Nov 25	Reaffirmed	FY2025 revenue $2.68-$2.74B, adjusted EBITDA $585-$605M, adjusted diluted EPS $2.00-$2.15 · full year
5 Aug 25	Reaffirmed	FY25 total revenue $2.60-2.81B; adjusted EBITDA $575-615M; adjusted EBITDA margin 22%; adjusted diluted EPS $2.07-2.57 · full year

QuidelOrtho Corporation — questions

What guidance did QuidelOrtho Corporation give?: On 2026-08-06: "FY2026 revenue $2.52-2.60B (from $2.70-2.75B); adjusted EBITDA $540-560M (from $615-630M)"
When does QuidelOrtho Corporation report earnings?: QuidelOrtho Corporation's next earnings report is expected on 2026-11-03.

Every figure on this page comes from QuidelOrtho Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.